AstraZeneca PLC (AZN)
75.17
+0.14
(+0.19%)
USD |
NASDAQ |
Apr 26, 16:00
75.17
0.00 (0.00%)
After-Hours: 20:00
AstraZeneca Cash from Operations (Quarterly): 2.38B for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.38B |
| September 30, 2023 | 3.114B |
| June 30, 2023 | 1.718B |
| March 31, 2023 | 3.133B |
| December 31, 2022 | 2.398B |
| September 30, 2022 | 2.93B |
| June 30, 2022 | 1.248B |
| March 31, 2022 | 3.232B |
| December 31, 2021 | 1.418B |
| September 30, 2021 | 1.719B |
| June 30, 2021 | 892.00M |
| March 31, 2021 | 1.934B |
| December 31, 2020 | 1.798B |
| September 30, 2020 | 1.822B |
| June 30, 2020 | 1.04B |
| March 31, 2020 | 139.00M |
| December 31, 2019 | 1.375B |
| September 30, 2019 | 1.103B |
| June 30, 2019 | 878.00M |
| March 31, 2019 | -387.00M |
| December 31, 2018 | 2.224B |
| September 30, 2018 | 469.00M |
| June 30, 2018 | 65.00M |
| March 31, 2018 | -140.00M |
| December 31, 2017 | 997.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.243B |
| June 30, 2017 | 250.00M |
| March 31, 2017 | 88.00M |
| December 31, 2016 | 1.96B |
| September 30, 2016 | 811.00M |
| June 30, 2016 | 181.00M |
| March 31, 2016 | 1.193B |
| December 31, 2015 | 571.00M |
| September 30, 2015 | 1.745B |
| June 30, 2015 | 1.08B |
| March 31, 2015 | -72.00M |
| December 31, 2014 | 1.842B |
| September 30, 2014 | 1.95B |
| June 30, 2014 | 2.079B |
| March 31, 2014 | 1.187B |
| December 31, 2013 | 2.478B |
| September 30, 2013 | 1.118B |
| June 30, 2013 | 1.606B |
| March 31, 2013 | 2.198B |
| December 31, 2012 | 2.848B |
| September 30, 2012 | 1.309B |
| June 30, 2012 | 1.251B |
| March 31, 2012 | 1.54B |
| December 31, 2011 | 3.069B |
| September 30, 2011 | 1.923B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
139.00M
Minimum
Mar 2020
3.232B
Maximum
Mar 2022
1.804B
Average
1.719B
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| GSK PLC | 3.899B |
| Amgen Inc | 538.00M |
| Sanofi SA | -- |
| Viking Therapeutics Inc | -6.134M |
| Fusion Pharmaceuticals Inc | -17.94M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.077B |
| Cash from Financing (Quarterly) | -291.00M |
| Free Cash Flow | 6.567B |
| Free Cash Flow Per Share (Quarterly) | 0.4573 |
| Free Cash Flow to Equity (Quarterly) | 1.537B |
| Free Cash Flow to Firm (Quarterly) | 1.801B |
| Free Cash Flow Yield | 2.80% |